A detailed history of Xponance, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Xponance, Inc. holds 18,115 shares of IONS stock, worth $719,346. This represents 0.01% of its overall portfolio holdings.

Number of Shares
18,115
Previous 16,209 11.76%
Holding current value
$719,346
Previous $702,000 22.93%
% of portfolio
0.01%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$36.45 - $47.7 $69,473 - $90,916
1,906 Added 11.76%
18,115 $863,000
Q1 2024

May 13, 2024

SELL
$42.03 - $53.55 $20,342 - $25,918
-484 Reduced 2.9%
16,209 $702,000
Q4 2023

Jan 31, 2024

SELL
$43.39 - $51.63 $49,594 - $59,013
-1,143 Reduced 6.41%
16,693 $844,000
Q3 2023

Oct 23, 2023

SELL
$38.5 - $47.13 $16,555 - $20,265
-430 Reduced 2.35%
17,836 $809,000
Q2 2023

Jul 13, 2023

BUY
$34.73 - $43.33 $11,773 - $14,688
339 Added 1.89%
18,266 $749,000
Q1 2023

Apr 17, 2023

BUY
$33.58 - $41.2 $7,286 - $8,940
217 Added 1.23%
17,927 $640,000
Q4 2022

Jan 23, 2023

BUY
$37.12 - $46.52 $80,550 - $100,948
2,170 Added 13.96%
17,710 $0
Q3 2022

Oct 24, 2022

BUY
$36.54 - $48.66 $4,457 - $5,936
122 Added 0.79%
15,540 $687,000
Q2 2022

Aug 02, 2022

BUY
$31.71 - $43.0 $16,489 - $22,360
520 Added 3.49%
15,418 $571,000
Q1 2022

Apr 20, 2022

BUY
$29.88 - $37.04 $239 - $296
8 Added 0.05%
14,898 $552,000
Q4 2021

Jan 31, 2022

BUY
$25.61 - $35.1 $8,143 - $11,161
318 Added 2.18%
14,890 $453,000
Q3 2021

Nov 05, 2021

SELL
$33.54 - $40.55 $21,935 - $26,519
-654 Reduced 4.3%
14,572 $489,000
Q2 2021

Aug 12, 2021

BUY
$34.54 - $47.25 $290,930 - $397,986
8,423 Added 123.81%
15,226 $607,000
Q1 2021

May 10, 2021

BUY
$42.51 - $63.78 $977 - $1,466
23 Added 0.34%
6,803 $306,000
Q4 2020

Feb 11, 2021

BUY
$45.3 - $60.27 $9,467 - $12,596
209 Added 3.18%
6,780 $383,000
Q3 2020

Oct 26, 2020

SELL
$47.45 - $62.95 $10,201 - $13,534
-215 Reduced 3.17%
6,571 $312,000
Q2 2020

Aug 14, 2020

BUY
$46.85 - $61.05 $317,924 - $414,285
6,786 New
6,786 $400,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.64B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Xponance, Inc. Portfolio

Follow Xponance, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.